![Kevin Tan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Tan
Director of Finance/CFO at
SOLID BIOSCIENCES INC.
Net worth: 993 226 $ as of 2026-06-29
Profile
Kevin Tan is currently Chief Financial Officer & Treasurer at Solid Biosciences, Inc. since 2023.
Former roles include Treasurer at Sarepta Therapeutics, Inc. from 2020 to 2021, Chief Financial & Accounting Officer at Selecta Biosciences, Inc. from 2021 to 2022, and Senior Portfolio Manager at CPP Investments Ltd. Education includes undergraduate studies at Queen's University, graduate studies at Princeton University, and an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-17 | 99,422 ( 0.1% ) | 993 226 $ | 2026-06-29 |
Kevin Tan active positions
| Companies | Position | Start |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director of Finance/CFO | 2023-01-08 |
Former positions of Kevin Tan
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 2022-11-27 |
| SAREPTA THERAPEUTICS, INC. | Treasurer | 2021-08-31 |
CPP Investments Ltd.
 CPP Investments Ltd. Investment ManagersFinance Provides investment management services | Corporate Officer/Principal | - |
Training of Kevin Tan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
CPP Investments Ltd.
CPP Investments Ltd. Investment ManagersFinance Provides investment management services | Finance |
- Stock Market
- Insiders
- Kevin Tan
Choose MarketScreener 
